Cas:155536-45-1 (5α,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19 -dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1) manufacturer & supplier

Chemical Name:(5α,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19 -dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1)

CAS.NO:155536-45-1

Synonyms:(5β,6β,14β,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1);6,14-Ethenomorphinan-3-ol, 4,5-epoxy-18,19-dihydro-18-[(1R)-1-hydroxy-1-methylbutyl]-6-methoxy-17-methyl-, (5β,6β,14β,18R)-, hydrochloride (1:1)

Molecular Formula:C₂₅H₃₆ClNO₄

Molecular Weight:450.011

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:554.2ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:62.16000

Exact Mass:449.233276

LogP:4.12750

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (5β,6β,14β,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6,14-Ethenomorphinan-3-ol, 4,5-epoxy-18,19-dihydro-18-[(1R)-1-hydroxy-1-methylbutyl]-6-methoxy-17-methyl-, (5β,6β,14β,18R)-, hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(5β,6β,14β,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1) Use and application,6,14-Ethenomorphinan-3-ol, 4,5-epoxy-18,19-dihydro-18-[(1R)-1-hydroxy-1-methylbutyl]-6-methoxy-17-methyl-, (5β,6β,14β,18R)-, hydrochloride (1:1) technical grade,usp/ep/jp grade.

Related News: Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. (5α,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19 -dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1) manufacturer In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. (5α,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19 -dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1) supplier In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. (5α,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19 -dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1) vendor The memo denies the company made false statements to the FDA. In their complaint, employees said they were broadly concerned that quality control documents the FDA requires companies to maintain had been rewritten or fabricated. The employees did not specify whether these materials had been shown to the FDA. (5α,18R)-18-[(2R)-2-Hydroxy-2-pentanyl]-6-methoxy-17-methyl-18,19 -dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol hydrochloride (1:1) factory What’s the background?